Page last updated: 2024-11-03

propofol and Bannayan-Riley-Ruvalcaba Syndrome

propofol has been researched along with Bannayan-Riley-Ruvalcaba Syndrome in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pancaro, C1
Miller, T1
Dingeman, RS1

Other Studies

1 other study available for propofol and Bannayan-Riley-Ruvalcaba Syndrome

ArticleYear
Anesthetic management of a child with Bannayan-Riley-Ruvalcaba syndrome.
    Anesthesia and analgesia, 2008, Volume: 106, Issue:6

    Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Child; Female; Hamartoma Syndrome, Multiple; Hema

2008
chemdatabank.com